id	sid	tid	token	lemma	pos
ct-10278	1	1	luteinizing	luteinize	VERB
ct-10278	1	2	hormone	hormone	NOUN
ct-10278	1	3	receptor	receptor	NOUN
ct-10278	1	4	mediated	mediate	VERB
ct-10278	1	5	proliferation	proliferation	NOUN
ct-10278	1	6	of	of	ADP
ct-10278	1	7	isolated	isolated	ADJ
ct-10278	1	8	canine	canine	PROPN
ct-10278	1	9	t	t	PROPN
ct-10278	1	10	lymphoma	lymphoma	NOUN
ct-10278	1	11	cells	cell	NOUN
ct-10278	1	12	luteinizing	luteinize	VERB
ct-10278	1	13	hormone	hormone	NOUN
ct-10278	1	14	receptor	receptor	NOUN
ct-10278	1	15	mediated	mediate	VERB
ct-10278	1	16	proliferation	proliferation	NOUN
ct-10278	1	17	of	of	ADP
ct-10278	1	18	isolated	isolated	ADJ
ct-10278	1	19	canine	canine	PROPN
ct-10278	1	20	t	t	PROPN
ct-10278	1	21	lymphoma	lymphoma	NOUN
ct-10278	1	22	cells	cell	NOUN
ct-10278	1	23	camryn	camryn	PROPN
ct-10278	1	24	flint	flint	PROPN
ct-10278	1	25	,	,	PUNCT
ct-10278	1	26	sabrina	sabrina	PROPN
ct-10278	1	27	gust	gust	PROPN
ct-10278	1	28	,	,	PUNCT
ct-10278	1	29	michelle	michelle	PROPN
ct-10278	1	30	kutzler	kutzler	PROPN
ct-10278	1	31	department	department	PROPN
ct-10278	1	32	of	of	ADP
ct-10278	1	33	animal	animal	NOUN
ct-10278	1	34	and	and	CCONJ
ct-10278	1	35	rangeland	rangeland	NOUN
ct-10278	1	36	sciences	science	NOUN
ct-10278	1	37	,	,	PUNCT
ct-10278	1	38	oregon	oregon	PROPN
ct-10278	1	39	state	state	PROPN
ct-10278	1	40	university	university	PROPN
ct-10278	1	41	,	,	PUNCT
ct-10278	1	42	corvallis	corvallis	PROPN
ct-10278	1	43	,	,	PUNCT
ct-10278	1	44	or	or	CCONJ
ct-10278	1	45	luteinizing	luteinize	VERB
ct-10278	1	46	hormone	hormone	NOUN
ct-10278	1	47	receptor	receptor	NOUN
ct-10278	1	48	(	(	PUNCT
ct-10278	1	49	lhr	lhr	PROPN
ct-10278	1	50	)	)	PUNCT
ct-10278	1	51	have	have	AUX
ct-10278	1	52	been	be	AUX
ct-10278	1	53	identified	identify	VERB
ct-10278	1	54	in	in	ADP
ct-10278	1	55	nonreproductive	nonreproductive	ADJ
ct-10278	1	56	tissues	tissue	NOUN
ct-10278	1	57	,	,	PUNCT
ct-10278	1	58	including	include	VERB
ct-10278	1	59	in	in	ADP
ct-10278	1	60	canine	canine	NOUN
ct-10278	1	61	lymphoma	lymphoma	NOUN
ct-10278	1	62	and	and	CCONJ
ct-10278	1	63	isolated	isolated	ADJ
ct-10278	1	64	canine	canine	PROPN
ct-10278	1	65	t	t	PROPN
ct-10278	1	66	lymphoma	lymphoma	VERB
ct-10278	1	67	cells.1	cells.1	PROPN
ct-10278	1	68	the	the	DET
ct-10278	1	69	objective	objective	NOUN
ct-10278	1	70	was	be	AUX
ct-10278	1	71	to	to	PART
ct-10278	1	72	determine	determine	VERB
ct-10278	1	73	if	if	SCONJ
ct-10278	1	74	the	the	DET
ct-10278	1	75	lhr	lhr	NOUN
ct-10278	1	76	in	in	ADP
ct-10278	1	77	canine	canine	PROPN
ct-10278	1	78	t	t	PROPN
ct-10278	1	79	lymphoma	lymphoma	NOUN
ct-10278	1	80	cells	cell	NOUN
ct-10278	1	81	was	be	AUX
ct-10278	1	82	functional	functional	ADJ
ct-10278	1	83	.	.	PUNCT
ct-10278	2	1	it	it	PRON
ct-10278	2	2	was	be	AUX
ct-10278	2	3	hypothesized	hypothesize	VERB
ct-10278	2	4	that	that	SCONJ
ct-10278	2	5	stimulation	stimulation	NOUN
ct-10278	2	6	of	of	ADP
ct-10278	2	7	the	the	DET
ct-10278	2	8	lhr	lhr	NOUN
ct-10278	2	9	by	by	ADP
ct-10278	2	10	human	human	ADJ
ct-10278	2	11	chorionic	chorionic	ADJ
ct-10278	2	12	gonadotropin	gonadotropin	NOUN
ct-10278	2	13	(	(	PUNCT
ct-10278	2	14	hcg	hcg	PROPN
ct-10278	2	15	)	)	PUNCT
ct-10278	2	16	or	or	CCONJ
ct-10278	2	17	canine	canine	VERB
ct-10278	2	18	lh	lh	PROPN
ct-10278	2	19	(	(	PUNCT
ct-10278	2	20	clh	clh	NOUN
ct-10278	2	21	)	)	PUNCT
ct-10278	2	22	induces	induce	VERB
ct-10278	2	23	proliferation	proliferation	NOUN
ct-10278	2	24	of	of	ADP
ct-10278	2	25	canine	canine	PROPN
ct-10278	2	26	t	t	PROPN
ct-10278	2	27	lymphoma	lymphoma	NOUN
ct-10278	2	28	cells	cell	NOUN
ct-10278	2	29	in	in	ADP
ct-10278	2	30	vitro	vitro	X
ct-10278	2	31	.	.	PUNCT
ct-10278	3	1	immortalized	immortalize	VERB
ct-10278	3	2	t	t	PROPN
ct-10278	3	3	cell	cell	NOUN
ct-10278	3	4	lines	line	NOUN
ct-10278	3	5	from	from	ADP
ct-10278	3	6	3	3	NUM
ct-10278	3	7	dogs	dog	NOUN
ct-10278	3	8	with	with	ADP
ct-10278	3	9	multicentric	multicentric	ADJ
ct-10278	3	10	t	t	PROPN
ct-10278	3	11	cell	cell	NOUN
ct-10278	3	12	lymphoma	lymphoma	NOUN
ct-10278	3	13	donated	donate	VERB
ct-10278	3	14	from	from	ADP
ct-10278	3	15	dr	dr	PROPN
ct-10278	3	16	.	.	PROPN
ct-10278	3	17	takuya	takuya	PROPN
ct-10278	3	18	mizuno	mizuno	PROPN
ct-10278	3	19	at	at	ADP
ct-10278	3	20	yamaguchi	yamaguchi	PROPN
ct-10278	3	21	university	university	PROPN
ct-10278	3	22	,	,	PUNCT
ct-10278	3	23	japan	japan	PROPN
ct-10278	3	24	were	be	AUX
ct-10278	3	25	plated	plate	VERB
ct-10278	3	26	in	in	ADP
ct-10278	3	27	96	96	NUM
ct-10278	3	28	well	well	ADJ
ct-10278	3	29	plates	plate	NOUN
ct-10278	3	30	in	in	ADP
ct-10278	3	31	rpmi	rpmi	NOUN
ct-10278	3	32	1640	1640	NUM
ct-10278	3	33	(	(	PUNCT
ct-10278	3	34	phenol	phenol	NOUN
ct-10278	3	35	and	and	CCONJ
ct-10278	3	36	protein	protein	NOUN
ct-10278	3	37	free	free	ADJ
ct-10278	3	38	)	)	PUNCT
ct-10278	3	39	media	medium	NOUN
ct-10278	3	40	(	(	PUNCT
ct-10278	3	41	#	#	SYM
ct-10278	3	42	02	02	NUM
ct-10278	3	43	-	-	PUNCT
ct-10278	3	44	0105	0105	NUM
ct-10278	3	45	,	,	PUNCT
ct-10278	3	46	vwr	vwr	PROPN
ct-10278	3	47	life	life	PROPN
ct-10278	3	48	science	science	PROPN
ct-10278	3	49	,	,	PUNCT
ct-10278	3	50	sanborn	sanborn	PROPN
ct-10278	3	51	,	,	PUNCT
ct-10278	3	52	ny	ny	PROPN
ct-10278	3	53	)	)	PUNCT
ct-10278	3	54	at	at	ADP
ct-10278	3	55	370c	370c	NUM
ct-10278	3	56	with	with	ADP
ct-10278	3	57	5	5	NUM
ct-10278	3	58	%	%	NOUN
ct-10278	3	59	co2	co2	NOUN
ct-10278	3	60	.	.	PUNCT
ct-10278	4	1	for	for	ADP
ct-10278	4	2	each	each	DET
ct-10278	4	3	cell	cell	NOUN
ct-10278	4	4	line	line	NOUN
ct-10278	4	5	,	,	PUNCT
ct-10278	4	6	standard	standard	ADJ
ct-10278	4	7	curves	curve	NOUN
ct-10278	4	8	from	from	ADP
ct-10278	4	9	10	10	NUM
ct-10278	4	10	to	to	PART
ct-10278	4	11	500	500	NUM
ct-10278	4	12	x	x	SYM
ct-10278	4	13	103	103	NUM
ct-10278	4	14	cells	cell	NOUN
ct-10278	4	15	/	/	SYM
ct-10278	4	16	well	well	INTJ
ct-10278	4	17	were	be	AUX
ct-10278	4	18	plated	plate	VERB
ct-10278	4	19	in	in	ADP
ct-10278	4	20	triplicate	triplicate	NOUN
ct-10278	4	21	.	.	PUNCT
ct-10278	5	1	increasing	increase	VERB
ct-10278	5	2	concentrations	concentration	NOUN
ct-10278	5	3	of	of	ADP
ct-10278	5	4	hcg	hcg	PROPN
ct-10278	5	5	(	(	PUNCT
ct-10278	5	6	4	4	NUM
ct-10278	5	7	40,000	40,000	NUM
ct-10278	5	8	u	u	NOUN
ct-10278	5	9	/	/	SYM
ct-10278	5	10	ml	ml	PROPN
ct-10278	5	11	,	,	PUNCT
ct-10278	5	12	chorulon	chorulon	NOUN
ct-10278	5	13	®	®	PROPN
ct-10278	5	14	,	,	PUNCT
ct-10278	5	15	merck	merck	PROPN
ct-10278	5	16	animal	animal	NOUN
ct-10278	5	17	health	health	PROPN
ct-10278	5	18	,	,	PUNCT
ct-10278	5	19	madison	madison	PROPN
ct-10278	5	20	,	,	PUNCT
ct-10278	5	21	nj	nj	PROPN
ct-10278	5	22	)	)	PUNCT
ct-10278	5	23	or	or	CCONJ
ct-10278	5	24	canine	canine	VERB
ct-10278	5	25	lh	lh	PROPN
ct-10278	5	26	(	(	PUNCT
ct-10278	5	27	0.002	0.002	NUM
ct-10278	5	28	to	to	PART
ct-10278	5	29	20	20	NUM
ct-10278	5	30	ng	ng	NOUN
ct-10278	5	31	/	/	SYM
ct-10278	5	32	ml	ml	NOUN
ct-10278	5	33	,	,	PUNCT
ct-10278	5	34	#	#	NOUN
ct-10278	5	35	qp604	qp604	PROPN
ct-10278	5	36	-	-	PUNCT
ct-10278	5	37	ec	ec	PROPN
ct-10278	5	38	,	,	PUNCT
ct-10278	5	39	enquire	enquire	VERB
ct-10278	5	40	bioreagents	bioreagent	NOUN
ct-10278	5	41	,	,	PUNCT
ct-10278	5	42	denver	denver	PROPN
ct-10278	5	43	,	,	PUNCT
ct-10278	5	44	co	co	NOUN
ct-10278	5	45	)	)	PUNCT
ct-10278	5	46	were	be	AUX
ct-10278	5	47	added	add	VERB
ct-10278	5	48	to	to	ADP
ct-10278	5	49	wells	well	NOUN
ct-10278	5	50	containing	contain	VERB
ct-10278	5	51	100	100	NUM
ct-10278	5	52	x	x	SYM
ct-10278	5	53	103	103	NUM
ct-10278	5	54	cells	cell	NOUN
ct-10278	5	55	plated	plate	VERB
ct-10278	5	56	in	in	ADP
ct-10278	5	57	triplicate	triplicate	NOUN
ct-10278	5	58	.	.	PUNCT
ct-10278	6	1	plates	plate	NOUN
ct-10278	6	2	were	be	AUX
ct-10278	6	3	incubated	incubate	VERB
ct-10278	6	4	for	for	ADP
ct-10278	6	5	24	24	NUM
ct-10278	6	6	,	,	PUNCT
ct-10278	6	7	48	48	NUM
ct-10278	6	8	,	,	PUNCT
ct-10278	6	9	and	and	CCONJ
ct-10278	6	10	72	72	NUM
ct-10278	6	11	hours	hour	NOUN
ct-10278	6	12	for	for	ADP
ct-10278	6	13	hcg	hcg	PROPN
ct-10278	6	14	or	or	CCONJ
ct-10278	6	15	48	48	NUM
ct-10278	6	16	,	,	PUNCT
ct-10278	6	17	72	72	NUM
ct-10278	6	18	,	,	PUNCT
ct-10278	6	19	96	96	NUM
ct-10278	6	20	,	,	PUNCT
ct-10278	6	21	and	and	CCONJ
ct-10278	6	22	120	120	NUM
ct-10278	6	23	hours	hour	NOUN
ct-10278	6	24	for	for	ADP
ct-10278	6	25	clh	clh	NOUN
ct-10278	6	26	before	before	SCONJ
ct-10278	6	27	cells	cell	NOUN
ct-10278	6	28	were	be	AUX
ct-10278	6	29	counted	count	VERB
ct-10278	6	30	using	use	VERB
ct-10278	6	31	an	an	DET
ct-10278	6	32	mtt	mtt	NOUN
ct-10278	6	33	cell	cell	NOUN
ct-10278	6	34	proliferation	proliferation	NOUN
ct-10278	6	35	assay	assay	NOUN
ct-10278	6	36	kit	kit	NOUN
ct-10278	6	37	(	(	PUNCT
ct-10278	6	38	#	#	SYM
ct-10278	6	39	10009365	10009365	NUM
ct-10278	6	40	,	,	PUNCT
ct-10278	6	41	cayman	cayman	NOUN
ct-10278	6	42	chemical	chemical	PROPN
ct-10278	6	43	,	,	PUNCT
ct-10278	6	44	ann	ann	PROPN
ct-10278	6	45	arbor	arbor	PROPN
ct-10278	6	46	,	,	PUNCT
ct-10278	6	47	mi	mi	PROPN
ct-10278	6	48	)	)	PUNCT
ct-10278	6	49	following	follow	VERB
ct-10278	6	50	manufacturer	manufacturer	NOUN
ct-10278	6	51	's	's	PART
ct-10278	6	52	instructions	instruction	NOUN
ct-10278	6	53	.	.	PUNCT
ct-10278	7	1	average	average	ADJ
ct-10278	7	2	±	±	PROPN
ct-10278	7	3	sd	sd	ADP
ct-10278	7	4	cell	cell	NOUN
ct-10278	7	5	number	number	NOUN
ct-10278	7	6	was	be	AUX
ct-10278	7	7	compared	compare	VERB
ct-10278	7	8	among	among	ADP
ct-10278	7	9	hormone	hormone	NOUN
ct-10278	7	10	concentrations	concentration	NOUN
ct-10278	7	11	using	use	VERB
ct-10278	7	12	one	one	NUM
ct-10278	7	13	way	way	NOUN
ct-10278	7	14	anova	anova	PROPN
ct-10278	7	15	.	.	PUNCT
ct-10278	7	16	significance	significance	NOUN
ct-10278	7	17	was	be	AUX
ct-10278	7	18	defined	define	VERB
ct-10278	7	19	as	as	ADP
ct-10278	7	20	p	p	X
ct-10278	7	21	<	<	X
ct-10278	7	22	0.05	0.05	NUM
ct-10278	7	23	.	.	PUNCT
ct-10278	8	1	activation	activation	NOUN
ct-10278	8	2	of	of	ADP
ct-10278	8	3	lhr	lhr	NOUN
ct-10278	8	4	in	in	ADP
ct-10278	8	5	isolated	isolated	ADJ
ct-10278	8	6	canine	canine	PROPN
ct-10278	8	7	t	t	PROPN
ct-10278	8	8	lymphoma	lymphoma	NOUN
ct-10278	8	9	cells	cell	NOUN
ct-10278	8	10	induced	induce	VERB
ct-10278	8	11	significant	significant	ADJ
ct-10278	8	12	cell	cell	NOUN
ct-10278	8	13	proliferation	proliferation	NOUN
ct-10278	8	14	in	in	ADP
ct-10278	8	15	all	all	DET
ct-10278	8	16	3	3	NUM
ct-10278	8	17	cell	cell	NOUN
ct-10278	8	18	lines	line	NOUN
ct-10278	8	19	with	with	ADP
ct-10278	8	20	both	both	CCONJ
ct-10278	8	21	hcg	hcg	PROPN
ct-10278	8	22	and	and	CCONJ
ct-10278	8	23	clh	clh	NOUN
ct-10278	8	24	,	,	PUNCT
ct-10278	8	25	but	but	CCONJ
ct-10278	8	26	varied	varied	ADJ
ct-10278	8	27	among	among	ADP
ct-10278	8	28	concentrations	concentration	NOUN
ct-10278	8	29	and	and	CCONJ
ct-10278	8	30	incubation	incubation	NOUN
ct-10278	8	31	times	time	NOUN
ct-10278	8	32	.	.	PUNCT
ct-10278	9	1	greatest	great	ADJ
ct-10278	9	2	proliferation	proliferation	NOUN
ct-10278	9	3	from	from	ADP
ct-10278	9	4	hcg	hcg	PROPN
ct-10278	9	5	occurred	occur	VERB
ct-10278	9	6	with	with	ADP
ct-10278	9	7	40,000	40,000	NUM
ct-10278	9	8	u	u	NOUN
ct-10278	9	9	/	/	SYM
ct-10278	9	10	ml	ml	NOUN
ct-10278	9	11	after	after	ADP
ct-10278	9	12	72	72	NUM
ct-10278	9	13	hours	hour	NOUN
ct-10278	9	14	of	of	ADP
ct-10278	9	15	incubation	incubation	NOUN
ct-10278	9	16	in	in	ADP
ct-10278	9	17	all	all	DET
ct-10278	9	18	3	3	NUM
ct-10278	9	19	cell	cell	NOUN
ct-10278	9	20	lines	line	NOUN
ct-10278	9	21	.	.	PUNCT
ct-10278	10	1	greatest	great	ADJ
ct-10278	10	2	proliferation	proliferation	NOUN
ct-10278	10	3	from	from	ADP
ct-10278	10	4	clh	clh	NOUN
ct-10278	10	5	occurred	occur	VERB
ct-10278	10	6	with	with	ADP
ct-10278	10	7	2	2	NUM
ct-10278	10	8	ng	ng	NOUN
ct-10278	10	9	/	/	SYM
ct-10278	10	10	ml	ml	NOUN
ct-10278	10	11	after	after	ADP
ct-10278	10	12	96	96	NUM
ct-10278	10	13	hours	hour	NOUN
ct-10278	10	14	of	of	ADP
ct-10278	10	15	incubation	incubation	NOUN
ct-10278	10	16	in	in	ADP
ct-10278	10	17	all	all	DET
ct-10278	10	18	3	3	NUM
ct-10278	10	19	cell	cell	NOUN
ct-10278	10	20	lines	line	NOUN
ct-10278	10	21	.	.	PUNCT
ct-10278	11	1	however	however	ADV
ct-10278	11	2	,	,	PUNCT
ct-10278	11	3	there	there	PRON
ct-10278	11	4	was	be	VERB
ct-10278	11	5	a	a	DET
ct-10278	11	6	significant	significant	ADJ
ct-10278	11	7	decrease	decrease	NOUN
ct-10278	11	8	in	in	ADP
ct-10278	11	9	cell	cell	NOUN
ct-10278	11	10	counts	count	NOUN
ct-10278	11	11	following	follow	VERB
ct-10278	11	12	administration	administration	NOUN
ct-10278	11	13	of	of	ADP
ct-10278	11	14	clh	clh	PROPN
ct-10278	11	15	at	at	ADP
ct-10278	11	16	the	the	DET
ct-10278	11	17	highest	high	ADJ
ct-10278	11	18	concentration	concentration	NOUN
ct-10278	11	19	(	(	PUNCT
ct-10278	11	20	20	20	NUM
ct-10278	11	21	ng	ng	NOUN
ct-10278	11	22	/	/	SYM
ct-10278	11	23	ml	ml	NOUN
ct-10278	11	24	)	)	PUNCT
ct-10278	11	25	at	at	ADP
ct-10278	11	26	all	all	DET
ct-10278	11	27	times	time	NOUN
ct-10278	11	28	of	of	ADP
ct-10278	11	29	incubation	incubation	NOUN
ct-10278	11	30	.	.	PUNCT
ct-10278	12	1	to	to	ADP
ct-10278	12	2	the	the	DET
ct-10278	12	3	author	author	NOUN
ct-10278	12	4	's	's	PART
ct-10278	12	5	knowledge	knowledge	NOUN
ct-10278	12	6	,	,	PUNCT
ct-10278	12	7	this	this	PRON
ct-10278	12	8	was	be	AUX
ct-10278	12	9	the	the	DET
ct-10278	12	10	first	first	ADJ
ct-10278	12	11	study	study	NOUN
ct-10278	12	12	to	to	PART
ct-10278	12	13	provide	provide	VERB
ct-10278	12	14	evidence	evidence	NOUN
ct-10278	12	15	that	that	SCONJ
ct-10278	12	16	lhr	lhr	NOUN
ct-10278	12	17	in	in	ADP
ct-10278	12	18	nonreproductive	nonreproductive	ADJ
ct-10278	12	19	tissues	tissue	NOUN
ct-10278	12	20	is	be	AUX
ct-10278	12	21	functional	functional	ADJ
ct-10278	12	22	.	.	PUNCT
ct-10278	13	1	these	these	DET
ct-10278	13	2	findings	finding	NOUN
ct-10278	13	3	provided	provide	VERB
ct-10278	13	4	an	an	DET
ct-10278	13	5	explanation	explanation	NOUN
ct-10278	13	6	for	for	ADP
ct-10278	13	7	why	why	SCONJ
ct-10278	13	8	gonadectomized	gonadectomize	VERB
ct-10278	13	9	dogs	dog	NOUN
ct-10278	13	10	are	be	AUX
ct-10278	13	11	3	3	NUM
ct-10278	13	12	4	4	NUM
ct-10278	13	13	times	time	NOUN
ct-10278	13	14	more	more	ADV
ct-10278	13	15	likely	likely	ADJ
ct-10278	13	16	to	to	PART
ct-10278	13	17	develop	develop	VERB
ct-10278	13	18	lymphoma.2,3	lymphoma.2,3	ADJ
ct-10278	13	19	clinical	clinical	ADJ
ct-10278	13	20	trials	trial	NOUN
ct-10278	13	21	are	be	AUX
ct-10278	13	22	planned	plan	VERB
ct-10278	13	23	to	to	PART
ct-10278	13	24	include	include	VERB
ct-10278	13	25	lh	lh	PROPN
ct-10278	13	26	downregulation	downregulation	NOUN
ct-10278	13	27	with	with	ADP
ct-10278	13	28	conventional	conventional	ADJ
ct-10278	13	29	chemotherapy	chemotherapy	NOUN
ct-10278	13	30	in	in	ADP
ct-10278	13	31	efforts	effort	NOUN
ct-10278	13	32	to	to	PART
ct-10278	13	33	prolong	prolong	VERB
ct-10278	13	34	survival	survival	NOUN
ct-10278	13	35	times	time	NOUN
ct-10278	13	36	in	in	ADP
ct-10278	13	37	dogs	dog	NOUN
ct-10278	13	38	.	.	PUNCT
ct-10278	14	1	keywords	keyword	NOUN
ct-10278	14	2	:	:	PUNCT
ct-10278	15	1	cancer	cancer	NOUN
ct-10278	15	2	,	,	PUNCT
ct-10278	15	3	dog	dog	NOUN
ct-10278	15	4	,	,	PUNCT
ct-10278	15	5	human	human	ADJ
ct-10278	15	6	chorionic	chorionic	ADJ
ct-10278	15	7	gonadotropin	gonadotropin	NOUN
ct-10278	15	8	,	,	PUNCT
ct-10278	15	9	lymphocyte	lymphocyte	ADJ
ct-10278	15	10	,	,	PUNCT
ct-10278	15	11	mtt	mtt	PROPN
ct-10278	15	12	assay	assay	NOUN
ct-10278	15	13	references	reference	NOUN
ct-10278	15	14	1	1	NUM
ct-10278	15	15	.	.	PUNCT
ct-10278	16	1	ettinger	ettinger	PROPN
ct-10278	16	2	a	a	PROPN
ct-10278	16	3	,	,	PUNCT
ct-10278	16	4	gust	gust	PROPN
ct-10278	16	5	s	s	PROPN
ct-10278	16	6	,	,	PUNCT
ct-10278	16	7	kutzler	kutzler	PROPN
ct-10278	16	8	ma	ma	PROPN
ct-10278	16	9	:	:	PUNCT
ct-10278	16	10	luteinizing	luteinize	VERB
ct-10278	16	11	hormone	hormone	NOUN
ct-10278	16	12	receptor	receptor	NOUN
ct-10278	16	13	expression	expression	NOUN
ct-10278	16	14	in	in	ADP
ct-10278	16	15	normal	normal	ADJ
ct-10278	16	16	and	and	CCONJ
ct-10278	16	17	neoplastic	neoplastic	ADJ
ct-10278	16	18	canine	canine	NOUN
ct-10278	16	19	lymphocytes	lymphocyte	VERB
ct-10278	16	20	.	.	PUNCT
ct-10278	17	1	am	be	AUX
ct-10278	17	2	j	j	PROPN
ct-10278	17	3	vet	vet	NOUN
ct-10278	17	4	res	re	NOUN
ct-10278	17	5	(	(	PUNCT
ct-10278	17	6	accepted	accept	VERB
ct-10278	17	7	9/13/2018	9/13/2018	NUM
ct-10278	17	8	)	)	PUNCT
ct-10278	17	9	.	.	PUNCT
ct-10278	18	1	2	2	X
ct-10278	18	2	.	.	X
ct-10278	18	3	torres	torres	PROPN
ct-10278	18	4	de	de	X
ct-10278	18	5	la	la	X
ct-10278	18	6	riva	riva	PROPN
ct-10278	18	7	g	g	PROPN
ct-10278	18	8	,	,	PUNCT
ct-10278	18	9	hart	hart	PROPN
ct-10278	18	10	bl	bl	PROPN
ct-10278	18	11	,	,	PUNCT
ct-10278	18	12	farver	farver	PROPN
ct-10278	18	13	tb	tb	PROPN
ct-10278	18	14	,	,	PUNCT
ct-10278	18	15	et	et	PROPN
ct-10278	18	16	al	al	PROPN
ct-10278	18	17	:	:	PUNCT
ct-10278	18	18	neutering	neuter	VERB
ct-10278	18	19	dogs	dog	NOUN
ct-10278	18	20	:	:	PUNCT
ct-10278	18	21	effects	effect	NOUN
ct-10278	18	22	on	on	ADP
ct-10278	18	23	joint	joint	ADJ
ct-10278	18	24	disorders	disorder	NOUN
ct-10278	18	25	and	and	CCONJ
ct-10278	18	26	cancers	cancer	NOUN
ct-10278	18	27	in	in	ADP
ct-10278	18	28	golden	golden	ADJ
ct-10278	18	29	retrievers	retriever	NOUN
ct-10278	18	30	.	.	PUNCT
ct-10278	19	1	plos	plos	PROPN
ct-10278	19	2	one	one	NUM
ct-10278	19	3	.	.	PUNCT
ct-10278	20	1	2013;8(2	2013;8(2	NUM
ct-10278	20	2	)	)	PUNCT
ct-10278	20	3	.	.	PUNCT
ct-10278	21	1	3	3	X
ct-10278	21	2	.	.	X
ct-10278	21	3	zink	zink	PROPN
ct-10278	21	4	mc	mc	PROPN
ct-10278	21	5	,	,	PUNCT
ct-10278	21	6	farhoody	farhoody	NOUN
ct-10278	21	7	p	p	NOUN
ct-10278	21	8	,	,	PUNCT
ct-10278	21	9	elser	elser	NOUN
ct-10278	21	10	se	se	PROPN
ct-10278	21	11	,	,	PUNCT
ct-10278	21	12	et	et	PROPN
ct-10278	21	13	al	al	PROPN
ct-10278	21	14	:	:	PUNCT
ct-10278	21	15	evaluation	evaluation	NOUN
ct-10278	21	16	of	of	ADP
ct-10278	21	17	the	the	DET
ct-10278	21	18	risk	risk	NOUN
ct-10278	21	19	and	and	CCONJ
ct-10278	21	20	age	age	NOUN
ct-10278	21	21	of	of	ADP
ct-10278	21	22	onset	onset	NOUN
ct-10278	21	23	of	of	ADP
ct-10278	21	24	cancer	cancer	NOUN
ct-10278	21	25	and	and	CCONJ
ct-10278	21	26	behavioral	behavioral	ADJ
ct-10278	21	27	disorders	disorder	NOUN
ct-10278	21	28	in	in	ADP
ct-10278	21	29	gonadectomized	gonadectomize	VERB
ct-10278	21	30	vizslas	vizsla	NOUN
ct-10278	21	31	.	.	PUNCT
ct-10278	22	1	j	j	PROPN
ct-10278	22	2	am	be	AUX
ct-10278	22	3	vet	vet	NOUN
ct-10278	22	4	med	med	ADJ
ct-10278	22	5	assoc	assoc	NOUN
ct-10278	22	6	2014;244:309	2014;244:309	NUM
ct-10278	22	7	-	-	SYM
ct-10278	22	8	319	319	NUM
ct-10278	22	9	.	.	PUNCT
ct-10278	23	1	477	477	NUM
ct-10278	23	2	clinical	clinical	ADJ
ct-10278	23	3	theriogenology	theriogenology	NOUN
ct-10278	23	4	•	•	NOUN
ct-10278	23	5	volume	volume	NOUN
ct-10278	23	6	11	11	NUM
ct-10278	23	7	,	,	PUNCT
ct-10278	23	8	number	number	NOUN
ct-10278	23	9	3	3	NUM
ct-10278	23	10	•	•	NUM
ct-10278	23	11	september	september	PROPN
ct-10278	23	12	2019	2019	NUM
ct-10278	23	13	478clinical	478clinical	ADJ
ct-10278	23	14	theriogenology	theriogenology	NOUN
ct-10278	23	15	•	•	NOUN
ct-10278	23	16	volume	volume	NOUN
ct-10278	23	17	11	11	NUM
ct-10278	23	18	,	,	PUNCT
ct-10278	23	19	number	number	NOUN
ct-10278	23	20	3	3	NUM
ct-10278	23	21	•	•	NUM
ct-10278	23	22	september	september	PROPN
ct-10278	23	23	2019	2019	NUM
ct-10278	23	24	omniblank	omniblank	NOUN
ct-10278	23	25	:	:	PUNCT